Ep. 191 How One Platform Is Connecting Doctors, Dispensaries and Insurance in the Cannabis Industry with CannaLnx

Show Notes:Matthew Myro Rothman, cannabis medicine expert and CannaLnx Chief Science Officer and Vice President of Marketing since its founding in 2018, joins host, Heidi Schalk, to break down the world of medical cannabis, how it fits into traditional healthcare, and what the future holds for reimbursement and integration.Matthew shares his journey from growing up in Cleveland to studying philosophy in San Francisco, where he was introduced to the medical cannabis industry in 2003. He spent 15 years as a cultivator and consultant before transitioning to the digital side, joining the team behind CannaLnx and its parent company EM2P2.Topics covered include the difference between medical cannabis, adult use/recreational cannabis, and hemp under federal law; why cannabis remains a Schedule I substance despite tens of thousands of research studies; and how President Trump's 2024 executive order is pushing to reclassify medical cannabis to Schedule III. Matthew explains how CannaLnx is working with the American Council of Cannabis Medicine (ACCM) and third party administrators (TPAs) to create alternative wellness stipends that allow patients to be reimbursed for cannabis medicine purchases through traditional health insurance bundles, making it the first platform of its kind to do so.The conversation also covers CannaLnx's business model (transaction fees from dispensary partners, always free for patients and physicians), the challenge of bootstrapping in a stigmatized industry, and the upcoming merger of CannaLnx with FitTech to launch CannaHealth, a biomonitoring platform that tracks real-time bioactivity data during cannabis use.Bio:Matthew Myro Rothman is a man of varied interest and expertise; counting musician, actor, writer, personal trainer, high-performance coach, and podcaster among his talents and skills. Born and raised in Cleveland, Ohio, the values of hard work and education would become a mainstay in his life. After graduating with honors from Cleveland State University in 2003, Matthew moved to San Francisco to pursue a graduate degree in philosophy, cosmology and consciousness from the California Institute of Integral Studies. His introduction to the medical cannabis industry would come the following year while earning his Master’s degree. Matthew was hired by a fellow grad student as a plant care specialist for a medical cannabis nursery that provided clones to local dispensaries. The next 15 years were spent as an entrepreneur and consultant in cannabis cultivation—building or consulting on dozens of small-medium grows and owning a nursery that provided tens of thousands of clones to Harborside Oakland which, at the time, was the largest medical dispensary in the country.In 2018, Matthew joined the EM2P2/CannaLnx team and currently serves that organization as its Chief Science Officer and Vice President of Marketing. He is also the host of the Edge of Cannabis Medicine podcast where he interviews experts and innovators on the cutting edge of all things pertaining to medical cannabis.To connect with our guest, click on the links below:LinkedIn:  https://www.linkedin.com/in/matthew-myro/Website:  www.cannalnx.comConnect with me:LinkedIn:  https://www.linkedin.com/in/heidischalkcoaching/🎁 Grab your Spotlight to Scale Blueprint:  https://spotlighttoscale.com/blueprint🎁 Looking for the solution to missed calls and leaking revenue?  Check out Leah, our AI employee then get your free custom demo for your business:  myhlhgrowthsolutions.com/leah